top of page
  • facebook Fertile Mag
  • Instagram Fertile Mag
  • Twitter Fertile Mag
  • Youtube Fertile Mag
IOLife LOGO.png

Clinic Institute Of Life - Greece

New technics


Continuing our effort to enable even more couples to become parents, we are innovating une  once again and are the first to offer in Greece, in collaboration with the company IGENOMIX®, the new EMBRACE® test, which:

- Facilitates the identification of the embryos most likely to present a
chromosomal normality, without resorting to biopsy.
- Evaluates embryos based on their chromosomal analysis.
- Increases the chances of achieving pregnancy on the first attempt.


The EMBRACE® test is a non-invasive test to identify the embryos most likely to be chromosomally normal, without resorting to embryo biopsy. This information is particularly important because it helps clinical embryologists select the embryos most likely to be implanted. The chances of achieving pregnancy on the first attempt are thus increased.

Embryos obtained through the in vitro fertilization procedure naturally release, during their development in the laboratory, free circulating DNA, due to their development in a small amount of culture medium. During this development, the embryo releases its DNA into the culture medium. Our specialized embryologists collect this culture medium, according to a specific protocol, in order to have it analyzed.

This analysis of the culture medium thus makes it possible to detect the DNA released by the embryo. Each embryo is then classified according to the probabilities it presents of being a healthy embryo. The highest rated embryo has the best probability of containing the correct number of chromosomes, and therefore of being the ideal embryo for transfer.

The selection of a healthy embryo is of capital importance in order to increase the chances of success of a treatment. For this reason, this new possibility of carrying out the non-invasive EMBRACE® preimplantation test offers greater safety to couples wishing to increase the chances of pregnancy without resorting to invasive methods by giving them the opportunity to base their decision on more detailed information. .

We are one of the most important medically assisted procreation centers in Europe, but also the most advanced. The personalized treatments we offer, in combination with the most modern assisted reproduction methods we implement, have led to the best possible results, with remarkably high success rates.

The EMBRACE® test is indicated:

After several failures of implantation.
In case of weak ovarian response.
In case of poor quality embryos (too fragile to undergo a biopsy).



ERICA is the world's most advanced artificial intelligence classification system for embryos obtained by in vitro fertilization. The advanced algorithm implemented achieves up to 92.5% success, surpassing any other method used in the past in embryology laboratories.

The ERICA system performs an in-depth analysis to verify the chromosomal integrity and to evaluate the possibilities of implantation of each embryo, in a completely unprecedented way in the history of assisted procreation.


The successful outcome of an in vitro fertilization cycle depends to a large extent on the selection of embryos with the best chance of implanting in the endometrium. The ERICA system performs precise analysis according to more than twenty parameters for each embryo separately, most of which cannot be examined with the naked eye.


The ERICA system analyzes the morphological characteristics of each embryo and then ranks them according to their viability, from the most viable to the least viable. Thus, doctors as well as couples know exactly what the chances of getting a pregnancy are.


The ERICA system greatly facilitates the task of the embryologist, by identifying the most important parameters for each embryo, simply from a few photographs. By comparing these images, and using a large, continuously updated database of cases studied over time, the system intelligently 'learns' how to improve its accuracy performance.


Until recently, an embryologist used three parameters to determine the viability of an embryo. Today, the ERICA system analyzes and ranks based on twenty different parameters, most of which cannot be seen with the naked eye. This improves the accuracy of estimating the viability and implantation probabilities of each embryo.


The ERICA system algorithm is inspired by the complex neurological architecture of the human brain, in which a multitude of layers of interconnected neurons not only transmit information, but learn and improve through experience. Thus, the procedures are constantly perfected, improving the quality of the services offered by the embryology laboratory that uses it.

When does the analysis of the embryo by the ERICA system take place?


How does it work?


What are the benefits of using the ERICA system?

- The implantation rate is improved and the time to obtain a pregnancy is reduced

- It also enables transparent communication, which helps couples understand the procedure for selecting the appropriate embryo for transfer, and the resulting chances of success

- It also provides the embryologist with data of decisive importance that helps him in his decision-making

- It improves the prognostic model relating to the capacity for implantation of embryos

- It makes it possible to maintain a high level of quality in selection procedures.we

Cost of the service: 

180€ *

(* Independent of the number of embryos)



In its efforts to apply the most innovative methods and ensure optimal results and successful pregnancies, Institute of Life - IASO announces a scientific partnership with world-renowned clinical embryologist Dr. Jacques Cohen, paving the way for the application artificial intelligence (AI) technologies.

From now on, the latest AI technologies will be applied at the Institute of Life:

Install the revolutionary new AI system, which for the very first time will focus onthe selection of the most suitable sperm, aimed at significantly increasing the chances of successful egg fertilization.

Through the accumulation of large volumes of data, image analysis and intelligent software, AI will help IVF specialists and clinical embryologists to effectively manage even the most difficult assisted reproduction cases.

AI is the most promising form of modern assistive technology and is expected to play a prominent role in assisted reproduction in years to come.

True to its vision, Institute of Life – IASO will continue to invest in new technologies and new scientific partnerships, aimed at bringing couples closer to achieving their expectations!

Real-time sperm selection based on morphology, velocity and motility patterns

  • SiD Identifies, tracks and evaluates every sperm in the field of view, in real time

  • SiD extracts outcome-related semen parameters

  • Turns qualitative semen assessment into quantitative assessment

  • And it will learn from every cycle you ask for help

Detailed explanation of Dr. GIATRAS

fiche technique contact grece.png

Fertility in the human species is naturally low. Under optimal conditions, sperm with normal characteristics only fertilize the oocyte at the time of ovulation in 15% of cases, regardless of any female pathology. The appearance of ICSI constituted a real revolution in the field of medically assisted procreation by making it possible to obtain fertilization rates of around 75% for each oocyte. These very high fertilization rates unfortunately do not ensure proper embryonic development or implantation in many cases. 

Is it the lack of relevance of the selection of the spermatozoon by the human eye which could be at the origin of the development of an embryo incapable of being implanted secondarily?

To date, biological techniques for selecting the "good sperm" include:


2- Techniques based on the properties of the basal membrane

3- Electrophoresis techniques

4- Microfluidic devices


The techniques routinely used to analyze a semen sample do not allow the selection of one sperm cell among the others.

The development of the CASA (Computer Aided Sperm Analysis) technique in the 1990s brought a lot to the selection of the best spermatozoa. This tool, in addition to the analysis of the classic parameters of the sperm (concentration, mobility, morphology) analyzes finer parameters in terms of motility and morphology. Although very efficient, the CASA does not make it possible to evaluate the fertilizing potential of a spermatozoon.

Over the years embryologists have understood that the selection of the best spermatozoon is decisive

bottom of page